Table 1.
mRS 0–1 (n=502) | mRS 2–3 (n=259) | P-value* | |
---|---|---|---|
Baseline Characteristics | |||
Age, year, median [IQR] | 67 [57–77] | 80 [67–88] | <0.001 |
Males, n (%) | 268 (53.4) | 96 (37.1) | <0.001 |
Hypertension, n (%) | 348 (69.3) | 221 (85.3) | <0.001 |
Diabetes, n (%) | 112 (22.3) | 72 (27.8) | 0.11 |
Atrial Fibrillation, n (%) | 170 (33.9) | 147 (56.8) | <0.001 |
Antiplatelet use, n (%) | 187 (37.3) | 123 (47.5) | 0.004 |
Anticoagulant use, n (%) | 63 (12.5) | 49 (18.9) | 0.001 |
Stroke Presentation | |||
Initial blood glucose, mg/dL, median [IQR] | 119 [103–145] | 127 [104–164] | 0.008 |
NIHSS, median [IQR] | 15 [10–20] | 17 [12–22] | 0.001 |
ASPECTS, median [IQR] | 9 [8–10] | 9 [8–10] | 0.66 |
Proximal vessel occlusion, n (%) | 0.57 | ||
A1/A2 | 1 (0.2) | 2 (0.8) | |
ICA | 106 (21.1) | 48 (18.5) | |
M1 | 310 (61.8) | 161 (62.2) | |
M2 | 84 (16.7) | 47 (18.1) | |
M3 | 1 (0.2) | 1 (0.4) | |
Time from symptom onset to recanalization, minutes, median [IQR] | 289.5 [198.75–458.5] | 273.5 [190.0–431.5] | 0.35 |
Intravenous thrombolysis, n (%) | 263 (52.4) | 113 (43.6) | 0.03 |
Non-parametric or Chi-square test